Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitry V Kravchenko

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Acta Crystallographica. Section E, Crystallographic Communications|February 22, 2021
Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodiumIrina S Konovalova, Sergiy M Kovalenko, Dmitry V Kravchenko, et al.
Acta Crystallographica. Section E, Crystallographic Communications|September 17, 2020
(1<i>R</i>,3<i>S</i>)-3-(1<i>H</i>-Benzo[<i>d</i>]imidazol-2-yl)-1,2,2-tri-methyl-cyclo-pentane-1-carb-oxy-lic acid as a new anti-diabetic active pharmaceutical ingredientSergiy M Kovalenko, Irina S Konovalova, Sergiy I Merzlikin, et al.
Natural Product Research|June 7, 2006
Natural products as templates for bioactive compound libraries: part 2. Novel modifications of vasicine (peganine) core via efficient and regioselective generation of 3-lithiodeoxyvasicine and its stereoselective addition to aliphatic ketones section signSergey V Shevyakov, Olga I Davydova, Alex S Kiselyov, et al.
Acta Crystallographica. Section E, Crystallographic Communications|January 11, 2020
Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2<i>H</i>-1,2,6-thia-diazine-4-carboxyl-ateAlexandre V Ivachtchenko, Sergiy M Kovalenko, Dmitry V Kravchenko, et al.
Natural Product Research|June 7, 2006
Natural products as templates for bioactive compound libraries: synthesis of biaryl derivatives of (+/-)-vasicineSergey V Shevyakov, Olga I Davydova, Dmitry G Pershin, et al.
Journal of Combinatorial Chemistry|March 15, 2005
Parallel liquid-phase synthesis of N-substituted 6-aminosulfonyl-2-oxo-1,2-dihydroquinoline-4-carboxamide and 6-aminosulfonylquinoline-4-carboxamide derivativesAlexandre V Ivachtchenko, Vladimir V Kobak, Alexey P Ilyn, et al.
Applied Microbiology and Biotechnology|August 27, 2011
Highly sensitive field test lateral flow immunodiagnostics of PVX infectionYuri F Drygin, Anatoly N Blintsov, Vitaly G Grigorenko, et al.
Molecules (Basel, Switzerland)|August 12, 2022
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2Andrey A Ivashchenko, Bogdan A Zagribelnyy, Yan A Ivanenkov, et al.
European Journal of Medicinal Chemistry|January 24, 2020
Synthesis, biological evaluation and in silico modeling of novel integrase strand transfer inhibitors (INSTIs)Andrey A Ivashchenko, Yan A Ivanenkov, Angela G Koryakova, et al.
Heliyon|December 18, 2019
Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophene-2-carboxylateAlexandre V Ivachtchenko, Oleg D Mitkin, Dmitry V Kravchenko, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Acta Crystallographica. Section E, Crystallographic Communications|February 22, 2021
Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodiumIrina S Konovalova, Sergiy M Kovalenko, Dmitry V Kravchenko, et al.
Acta Crystallographica. Section E, Crystallographic Communications|September 17, 2020
(1<i>R</i>,3<i>S</i>)-3-(1<i>H</i>-Benzo[<i>d</i>]imidazol-2-yl)-1,2,2-tri-methyl-cyclo-pentane-1-carb-oxy-lic acid as a new anti-diabetic active pharmaceutical ingredientSergiy M Kovalenko, Irina S Konovalova, Sergiy I Merzlikin, et al.
Natural Product Research|June 7, 2006
Natural products as templates for bioactive compound libraries: part 2. Novel modifications of vasicine (peganine) core via efficient and regioselective generation of 3-lithiodeoxyvasicine and its stereoselective addition to aliphatic ketones section signSergey V Shevyakov, Olga I Davydova, Alex S Kiselyov, et al.
Acta Crystallographica. Section E, Crystallographic Communications|January 11, 2020
Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2<i>H</i>-1,2,6-thia-diazine-4-carboxyl-ateAlexandre V Ivachtchenko, Sergiy M Kovalenko, Dmitry V Kravchenko, et al.
Natural Product Research|June 7, 2006
Natural products as templates for bioactive compound libraries: synthesis of biaryl derivatives of (+/-)-vasicineSergey V Shevyakov, Olga I Davydova, Dmitry G Pershin, et al.
Journal of Combinatorial Chemistry|March 15, 2005
Parallel liquid-phase synthesis of N-substituted 6-aminosulfonyl-2-oxo-1,2-dihydroquinoline-4-carboxamide and 6-aminosulfonylquinoline-4-carboxamide derivativesAlexandre V Ivachtchenko, Vladimir V Kobak, Alexey P Ilyn, et al.
Applied Microbiology and Biotechnology|August 27, 2011
Highly sensitive field test lateral flow immunodiagnostics of PVX infectionYuri F Drygin, Anatoly N Blintsov, Vitaly G Grigorenko, et al.
Molecules (Basel, Switzerland)|August 12, 2022
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2Andrey A Ivashchenko, Bogdan A Zagribelnyy, Yan A Ivanenkov, et al.
European Journal of Medicinal Chemistry|January 24, 2020
Synthesis, biological evaluation and in silico modeling of novel integrase strand transfer inhibitors (INSTIs)Andrey A Ivashchenko, Yan A Ivanenkov, Angela G Koryakova, et al.
Heliyon|December 18, 2019
Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophene-2-carboxylateAlexandre V Ivachtchenko, Oleg D Mitkin, Dmitry V Kravchenko, et al.
Pageof 3